Harry Harvey

1.4k total citations
23 papers, 1.1k citations indexed

About

Harry Harvey is a scholar working on Oncology, Molecular Biology and Neurology. According to data from OpenAlex, Harry Harvey has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Harry Harvey's work include Neuroblastoma Research and Treatments (5 papers), Genetic factors in colorectal cancer (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Harry Harvey is often cited by papers focused on Neuroblastoma Research and Treatments (5 papers), Genetic factors in colorectal cancer (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Harry Harvey collaborates with scholars based in Ireland, United States and India. Harry Harvey's co-authors include Brian J. Harvey, Raymond L. Stallings, Jean McBryan, Isabella Bray, Olga Piskareva, Charles Vogel, John Hohneker, Barbara Weber, Joseph Bigley and Laura F. Hutchins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Harry Harvey

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry Harvey Ireland 14 448 423 342 152 139 23 1.1k
Nives Pećina‐Šlaus Croatia 18 810 1.8× 298 0.7× 261 0.8× 149 1.0× 118 0.8× 56 1.4k
Bin Chang China 21 717 1.6× 440 1.0× 308 0.9× 225 1.5× 61 0.4× 52 1.3k
Joseph J. Pinzone United States 17 696 1.6× 506 1.2× 167 0.5× 168 1.1× 106 0.8× 24 1.5k
Jonas Sjölund Sweden 18 887 2.0× 331 0.8× 299 0.9× 219 1.4× 120 0.9× 29 1.3k
Barbara Banelli Italy 27 1.2k 2.6× 441 1.0× 611 1.8× 127 0.8× 213 1.5× 58 1.8k
Kevin Ebata United States 14 992 2.2× 292 0.7× 179 0.5× 337 2.2× 128 0.9× 24 1.8k
Yinyan He China 23 613 1.4× 339 0.8× 450 1.3× 115 0.8× 27 0.2× 48 1.5k
Todd Seeley United States 12 685 1.5× 207 0.5× 413 1.2× 202 1.3× 47 0.3× 16 1.3k
Hiroki Odagiri Japan 16 713 1.6× 393 0.9× 161 0.5× 152 1.0× 68 0.5× 36 1.3k
Fabienne Escande France 22 713 1.6× 267 0.6× 196 0.6× 356 2.3× 68 0.5× 68 1.4k

Countries citing papers authored by Harry Harvey

Since Specialization
Citations

This map shows the geographic impact of Harry Harvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Harvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Harvey more than expected).

Fields of papers citing papers by Harry Harvey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Harvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Harvey. The network helps show where Harry Harvey may publish in the future.

Co-authorship network of co-authors of Harry Harvey

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Harvey. A scholar is included among the top collaborators of Harry Harvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Harvey. Harry Harvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harvey, Harry, Claire Brady, Seán J. Costelloe, et al.. (2024). Dealing with digital paralysis: Surviving a cyberattack in a National Cancer center. Journal of Cancer Policy. 39. 100466–100466. 7 indexed citations
2.
Harvey, Harry, et al.. (2023). Clinical boundaries in adult cases of large B cell lymphoma with IRF4 rearrangement. Histopathology. 84(2). 399–401. 1 indexed citations
3.
Harvey, Harry, Derek G. Power, Dearbhaile Catherine Collins, et al.. (2023). A pilot project investigating the use of ONCOpatient®—An electronic patient-reported outcomes app for oncology patients. Digital Health. 9. 589829140–589829140. 5 indexed citations
4.
Harvey, Harry, Verena Murphy, Jo Ballot, et al.. (2023). The Impact of a National Cyberattack Affecting Clinical Trials: The Cancer Trials Ireland Experience. JCO Clinical Cancer Informatics. 4 indexed citations
5.
Harvey, Brian J. & Harry Harvey. (2023). Sex Differences in Colon Cancer: Genomic and Nongenomic Signalling of Oestrogen. Genes. 14(12). 2225–2225. 12 indexed citations
6.
Harvey, Harry, et al.. (2022). Impact of Conti ransomware attack on cancer trials Ireland sites.. Journal of Clinical Oncology. 40(16_suppl). e13614–e13614. 1 indexed citations
7.
Harvey, Harry, et al.. (2020). Sexual Dimorphism in Colon Cancer. Frontiers in Oncology. 10. 607909–607909. 120 indexed citations
8.
Harvey, Harry, et al.. (2019). Malignant melanoma arising from an end ileostomy. BMJ Case Reports. 12(7). e230265–e230265. 1 indexed citations
9.
Curtin, Caroline M., John Nolan, Ronald A. Conlon, et al.. (2018). A physiologically relevant 3D collagen-based scaffold–neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models. Acta Biomaterialia. 70. 84–97. 49 indexed citations
10.
11.
Rapetti‐Mauss, Raphaël, Warren Thomas, Jean McBryan, et al.. (2017). Bidirectional KCNQ1:β-catenin interaction drives colorectal cancer cell differentiation. Proceedings of the National Academy of Sciences. 114(16). 4159–4164. 56 indexed citations
12.
Nijhuis, Anke, Harry Harvey, Richard Poulsom, et al.. (2017). GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions. Oncotarget. 8(48). 84258–84275. 46 indexed citations
13.
Piskareva, Olga, Harry Harvey, John Nolan, et al.. (2015). The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro. Cancer Letters. 364(2). 142–155. 71 indexed citations
14.
Harvey, Harry, Olga Piskareva, Laura Creevey, et al.. (2014). Modulation of chemotherapeutic drug resistance in neuroblastoma SK‐N‐AS cells by the neural apoptosis inhibitory protein and mi R ‐520f. International Journal of Cancer. 136(7). 1579–1588. 30 indexed citations
15.
Pedram, Ali, Mahnaz Razandi, Fiona O’Mahony, et al.. (2013). Estrogen Reduces Lipid Content in the Liver Exclusively from Membrane Receptor Signaling. Science Signaling. 6(276). ra36–ra36. 89 indexed citations
16.
Tivnan, Amanda, W. Shannon Orr, Vladimir Gubala, et al.. (2012). Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles. PLoS ONE. 7(5). e38129–e38129. 190 indexed citations
17.
Dunham, David, et al.. (1997). CHEMOSENSORY ROLE OF ANTENNULES IN THE BEHAVIORAL INTEGRATION OF FEEDING BY THE CRAYFISH CAMBARUS BARTONII. Journal of Crustacean Biology. 17(1). 27–32. 17 indexed citations
18.
Weber, Barbara, Charles Vogel, Stephen E. Jones, et al.. (1995). Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer.. Journal of Clinical Oncology. 13(11). 2722–2730. 164 indexed citations
19.
Lipton, Allan, Laurence M. Demers, Christopher Hamilton, et al.. (1993). Increased urinary excretion of pyridinium cross-links in cancer patients.. PubMed. 39(4). 614–8. 53 indexed citations
20.
Manni, Andrea, Mary J. Bartholomew, Richard Caplan, et al.. (1988). Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome.. Journal of Clinical Oncology. 6(9). 1456–1466. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nives Pećina‐Šlaus Breakdown of academic impact, for papers by Bin Chang Breakdown of academic impact, for papers by Joseph J. Pinzone Breakdown of academic impact, for papers by Jonas Sjölund Breakdown of academic impact, for papers by Barbara Banelli Breakdown of academic impact, for papers by Kevin Ebata Breakdown of academic impact, for papers by Yinyan He Breakdown of academic impact, for papers by Todd Seeley Breakdown of academic impact, for papers by Hiroki Odagiri Breakdown of academic impact, for papers by Fabienne Escande
Rankless by CCL
2026